Paolo G Casali Selected Research

Ligands

8/2010	Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas.
2/2004	Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo G Casali Research Topics

Disease

51	Neoplasms (Cancer) 01/2023 - 02/2004
49	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2003
20	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 01/2003
10	Myxoid Liposarcoma 01/2023 - 07/2007
9	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2004
7	Chordoma 01/2022 - 11/2004
7	Disease Progression 01/2021 - 06/2012
6	Leiomyosarcoma 01/2023 - 07/2010
6	Dermatofibrosarcoma 01/2017 - 10/2005
5	Liposarcoma 01/2023 - 07/2007
4	Perivascular Epithelioid Cell Neoplasms 10/2020 - 10/2013
4	Chondrosarcoma 01/2019 - 02/2011
4	Alveolar Soft Part Sarcoma 01/2018 - 02/2009
4	Synovial Sarcoma (Synovioma) 07/2015 - 02/2004
4	Extraskeletal Myxoid Chondrosarcoma 06/2014 - 10/2012
3	Hypertension (High Blood Pressure) 01/2019 - 05/2012
3	Clear Cell Sarcoma 02/2015 - 02/2012
3	Solitary Fibrous Tumors 06/2014 - 05/2010
3	Fatigue 05/2012 - 09/2006
3	Nausea 05/2012 - 09/2006
2	Epithelioid Hemangioendothelioma 01/2021 - 01/2016
2	Cardiotoxicity 01/2020 - 04/2007
2	Melanoma (Melanoma, Malignant) 02/2015 - 02/2012
2	Fibrosarcoma 06/2014 - 10/2011
2	Genetic Translocation (Chromosomal Translocation) 11/2012 - 07/2007
1	Necrosis 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Menstruation Disturbances 01/2021
1	Rupture 01/2020
1	Osteolysis 01/2020
1	Osteonecrosis (Kienbock's Disease) 01/2020
1	Sepsis (Septicemia) 03/2019
1	Infections 03/2019
1	Neutropenia 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Mucositis 01/2018
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2016
1	Hemangiopericytoma 07/2016
1	Hemangioendothelioma 01/2016
1	Pleural Effusion (Pleural Effusions) 01/2016

Drug/Important Bio-Agent (IBA)

31	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 07/2004
15	TrabectedinIBA 01/2023 - 07/2007
9	Ifosfamide FDA LinkGeneric 01/2022 - 01/2015
9	AnthracyclinesIBA 01/2022 - 12/2013
9	Tyrosine Kinase InhibitorsIBA 08/2019 - 07/2004
8	Sunitinib (Sutent)FDA Link 02/2015 - 09/2007
5	pazopanib FDA Link 01/2020 - 05/2012
5	Gemcitabine FDA Link 01/2020 - 06/2014
5	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2015 - 11/2004
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2011 - 02/2004
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2007
4	Phosphotransferases (Kinase)IBA 10/2012 - 02/2004
3	nilotinib FDA Link 12/2021 - 09/2009
3	MTOR InhibitorsIBA 10/2020 - 08/2010
3	TOR Serine-Threonine KinasesIBA 10/2018 - 07/2013
2	multidrug resistance-associated protein 1IBA 12/2021 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2012
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 11/2015
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 11/2015 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 06/2015 - 11/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 02/2004
2	LigandsIBA 08/2010 - 02/2004
2	Dihydrotachysterol (AT 10)IBA 06/2007 - 10/2005
1	mifamurtideIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Brachyury protein (Brachyury)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	ripretinibIBA 12/2021
1	avapritinibIBA 12/2021
1	AZD 6244IBA 12/2021
1	Transcriptional Coactivator with PDZ-Binding Motif ProteinsIBA 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2020
1	exemestane (Aromasin)FDA Link 10/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Denosumab FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	BilirubinIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Semaphorins (Semaphorin)IBA 01/2019
1	Everolimus FDA Link 10/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2017
1	antineoplaston A10 (A 10)IBA 01/2016
1	Toremifene (Fareston)FDA Link 12/2015

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2023 - 01/2003
24	Therapeutics 01/2021 - 11/2004
11	Radiotherapy 01/2023 - 01/2007
5	Adjuvant Chemotherapy 01/2019 - 08/2004
3	Neoadjuvant Therapy 01/2023 - 09/2013
3	Molecular Targeted Therapy 10/2005 - 11/2004
2	Catheters 03/2019 - 09/2016
1	Hyperthermic Intraperitoneal Chemotherapy 01/2023
1	Laparotomy 10/2019
1	Immunotherapy 01/2017
1	Prostheses and Implants (Prosthesis) 09/2016
1	Embolectomy 09/2016